Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
GIRMX
Price
$23.41
Change
-$0.07 (-0.30%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs GIRMX

Header iconFNWFX vs GIRMX Comparison
Open Charts FNWFX vs GIRMXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Goldman Sachs Emerging Markets Eq I
Price$23.41
Change-$0.07 (-0.30%)
VolumeN/A
CapitalizationN/A
FNWFX vs GIRMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. GIRMX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and GIRMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. GIRMX (2.77B). FNWFX pays higher dividends than GIRMX: FNWFX (1.56) vs GIRMX (1.21). FNWFX was incepted earlier than GIRMX: FNWFX (8 years) vs GIRMX (14 years). FNWFX (32.00) and GIRMX (32.00) have comparable annual turnover. GIRMX has a lower initial minimum investment than FNWFX: GIRMX (0) vs FNWFX (1000000). GIRMX annual gain was more profitable for investors over the last year : 13.12 vs. FNWFX (11.59). FNWFX return over 5 years is better than : 17.23 vs. GIRMX (10.38).
FNWFXGIRMXFNWFX / GIRMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD7.14710.00971%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B2.77B2,198%
Annual Yield % from dividends1.561.21129%
Returns for 1 year11.5913.1288%
Returns for 3 years-14.49-23.1063%
Returns for 5 years17.2310.38166%
Returns for 10 yearsN/A47.09-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology